SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "(WFRF:(Oliva R)) srt2:(2015-2019) "

Sökning: (WFRF:(Oliva R)) srt2:(2015-2019)

  • Resultat 11-20 av 21
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
11.
  •  
12.
  • Caffau, E., et al. (författare)
  • Systematic investigation of chemical abundances derived using IR spectra obtained with GIANO
  • 2019
  • Ingår i: Astronomy and Astrophysics. - : EDP Sciences. - 0004-6361 .- 1432-0746. ; 622
  • Tidskriftsartikel (refereegranskat)abstract
    • Context. Detailed chemical abundances of Galactic stars are needed in order to improve our knowledge of the formation and evolution of our galaxy, the Milky Way. Aims. We took advantage of the GIANO archive spectra to select a sample of Galactic disc stars in order to derive their chemical inventory and to compare the abundances we derived from these infrared spectra to the chemical pattern derived from optical spectra. Methods. We analysed high-quality spectra of 40 stars observed with GIANO. We derived the stellar parameters from the photometry and the Gaia data-release 2 (DR2) parallax; the chemical abundances were derived with the code MyGIsFOS. For a subsample of stars we compared the chemical pattern derived from the GIANO spectra with the abundances derived from optical spectra. We derived P abundances for all 40 stars, increasing the number of Galactic stars for which phosphorus abundance is known. Results. We could derive abundances of 14 elements, 8 of which are also derived from optical spectra. The comparison of the abundances derived from infrared and optical spectra is very good. The chemical pattern of these stars is the one expected for Galactic disc stars and is in agreement with the results from the literature. Conclusions. GIANO is providing the astronomical community with an extremely useful instrument, able to produce spectra with high resolution and a wide wavelength range in the infrared.
  •  
13.
  • Gu, Y, et al. (författare)
  • Quick Hot Shot & Young Surgeon Presentation
  • 2015
  • Ingår i: Hernia : the journal of hernias and abdominal wall surgery. - 1248-9204. ; 19 Suppl 1, s. S77-84
  • Tidskriftsartikel (refereegranskat)
  •  
14.
  •  
15.
  • Masini, D, et al. (författare)
  • The histamine H3 receptor antagonist thioperamide rescues circadian rhythm and memory function in experimental parkinsonism
  • 2017
  • Ingår i: Translational psychiatry. - : Springer Science and Business Media LLC. - 2158-3188. ; 7:4, s. e1088-
  • Tidskriftsartikel (refereegranskat)abstract
    • Parkinson’s disease (PD) is a common neurodegenerative disorder, characterized by motor impairment and a wide range of non-motor symptoms, including sleep disorders and cognitive and affective deficits. In this study, we used a mouse model of PD based on 6-hydroxydopamine (6-OHDA) to examine the effect of thioperamide, a histamine H3 receptor antagonist, on circadian activity, recognition memory and anxiety. A partial, bilateral 6-OHDA lesion of the striatum reduces motor activity during the active phase of the 24 h cycle. In addition, the lesion disrupts the endogenous circadian rhythm observed when mice are maintained in constant darkness. Administration of thioperamide to 6-OHDA-lesion mice rescues the normal rest/activity cycle. Moreover, thioperamide counteracts the deficit of novel object recognition produced by 6-OHDA. Our experiments show that this memory impairment is accompanied by disrupted gamma oscillations in the hippocampus, which are also rescued by thioperamide. In contrast, we do not observe any modification of the anxiogenic effect of 6-OHDA in response to administration of thioperamide. Our results indicate that thioperamide may act as a multifunctional drug, able to counteract disruptions of circadian rhythm and cognitive deficits associated with PD.
  •  
16.
  •  
17.
  • Nieminen, Markku S., et al. (författare)
  • The patient perspective : Quality of life in advanced heart failure with frequent hospitalisations
  • 2015
  • Ingår i: International Journal of Cardiology. - : Elsevier BV. - 0167-5273 .- 1874-1754. ; 191, s. 256-264
  • Forskningsöversikt (refereegranskat)abstract
    • End of life is an unfortunate but inevitable phase of the heart failure patients' journey. It is often preceded by a stage in the progression of heart failure defined as advanced heart failure, and characterised by poor quality of life and frequent hospitalisations. In clinical practice, the efficacy of treatments for advanced heart failure is often assessed by parameters such as clinical status, haemodynamics, neurohormonal status, and echo/MRI indices. From the patients' perspective, however, quality-of-life-related parameters, such as functional capacity, exercise performance, psychological status, and frequency of re-hospitalisations, are more significant. The effects of therapies and interventions on these parameters are, however, underrepresented in clinical trials targeted to assess advanced heart failure treatment efficacy, and data are overall scarce. This is possibly due to a non-universal definition of the quality-of-life-related endpoints, and to the difficult standardisation of the data collection. These uncertainties also lead to difficulties in handling trade-off decisions between quality of life and survival by patients, families and healthcare providers. A panel of 34 experts in the field of cardiology and intensive cardiac care from 21 countries around the world convened for reviewing the existing data on quality-of-life in patients with advanced heart failure, discussing and reaching a consensus on the validity and significance of quality-of-life assessment methods. Gaps in routine care and research, which should be addressed, were identified. Finally, published data on the effects of current i.v. vasoactive therapies such as inotropes, inodilators, and vasodilators on quality-of-life in advanced heart failure patients were analysed.
  •  
18.
  •  
19.
  • Turrini, D., et al. (författare)
  • The contribution of the ARIEL space mission to the study of planetary formation
  • 2018
  • Ingår i: Experimental Astronomy. - : Springer Science and Business Media LLC. - 0922-6435 .- 1572-9508. ; 46:1, s. 45-65
  • Tidskriftsartikel (refereegranskat)abstract
    • The study of extrasolar planets and of the Solar System provides complementary pieces of the mosaic represented by the process of planetary formation. Exoplanets are essential to fully grasp the huge diversity of outcomes that planetary formation and the subsequent evolution of the planetary systems can produce. The orbital and basic physical data we currently possess for the bulk of the exoplanetary population, however, do not provide enough information to break the intrinsic degeneracy of their histories, as different evolutionary tracks can result in the same final configurations. The lessons learned from the Solar System indicate us that the solution to this problem lies in the information contained in the composition of planets. The goal of the Atmospheric Remote-Sensing Infrared Exoplanet Large-survey (ARIEL), one of the three candidates as ESA M4 space mission, is to observe a large and diversified population of transiting planets around a range of host star types to collect information on their atmospheric composition. ARIEL will focus on warm and hot planets to take advantage of their well-mixed atmospheres, which should show minimal condensation and sequestration of high-Z materials and thus reveal their bulk composition across all main cosmochemical elements. In this work we will review the most outstanding open questions concerning the way planets form and the mechanisms that contribute to create habitable environments that the compositional information gathered by ARIEL will allow to tackle.
  •  
20.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 11-20 av 21

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy